These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24706216)

  • 1. Dose adjustment of carboplatin in patients on peritoneal dialysis.
    Guddati AK; Joy PS; Marak CP
    Med Oncol; 2014 May; 31(5):946. PubMed ID: 24706216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic analysis of carboplatin in patients with cancer who are undergoing hemodialysis.
    Oguri T; Shimokata T; Inada M; Ito I; Ando Y; Sasaki Y; Hasegawa Y
    Cancer Chemother Pharmacol; 2010 Sep; 66(4):813-7. PubMed ID: 20563583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose adjustment of carboplatin in patients on hemodialysis.
    Guddati AK; Joy PS; Marak CP
    Med Oncol; 2014 Mar; 31(3):848. PubMed ID: 24452283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extension of the Calvert formula to patients with severe renal insufficiency.
    Oguri T; Shimokata T; Ito I; Yasuda Y; Sassa N; Nishiyama M; Hamada A; Hasegawa Y; Ando Y
    Cancer Chemother Pharmacol; 2015 Jul; 76(1):53-9. PubMed ID: 25957958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of Carboplatin in a One-Year-Old Anuric Boy Undergoing Hemodialysis and a Review of the Literature.
    Kamei K; Sako M; Ishikawa T; Sato M; Ogura M; Uno T; Kiyotani C; Mori T; Tanaka H; Ito S; Nakamura H
    Ther Apher Dial; 2015 Oct; 19(5):491-6. PubMed ID: 25916242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of carboplatin clearance calculated by patient characteristics or 24-hour creatinine clearance: a comparison of the performance of three formulae.
    Okamoto H; Nagatomo A; Kunitoh H; Kunikane H; Watanabe K
    Cancer Chemother Pharmacol; 1998; 42(4):307-12. PubMed ID: 9744776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measured versus estimated glomerular filtration rate in the Calvert equation: influence on carboplatin dosing.
    Donahue A; McCune JS; Faucette S; Gillenwater HH; Kowalski RJ; Socinski MA; Lindley C
    Cancer Chemother Pharmacol; 2001 May; 47(5):373-9. PubMed ID: 11391850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin and carboplatin pharmacokinetics in a pediatric patient with hepatoblastoma receiving peritoneal dialysis.
    Nijstad AL; van Eijkelenburg NKA; Kraal KCJM; Meijs MJM; de Kanter CTMM; Lilien MR; Huitema ADR
    Cancer Chemother Pharmacol; 2020 Sep; 86(3):445-449. PubMed ID: 32816154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboplatin dosage: prospective evaluation of a simple formula based on renal function.
    Calvert AH; Newell DR; Gumbrell LA; O'Reilly S; Burnell M; Boxall FE; Siddik ZH; Judson IR; Gore ME; Wiltshaw E
    J Clin Oncol; 2023 Oct; 41(28):4453-4454. PubMed ID: 37757592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Calvert's formula for dosage adjustment of carboplatin in Japanese patients with hormone refractory prostate cancer.
    Sato E; Yano I; Jiko M; Takahashi K; Motohashi H; Masuda S; Katsura T; Nishiyama H; Segawa T; Ito N; Kamoto T; Ogawa O; Inui K
    Biol Pharm Bull; 2006 Jul; 29(7):1441-4. PubMed ID: 16819185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboplatin-based chemotherapy in patients undergoing hemodialysis.
    Yanagawa H; Takishita Y; Bando H; Sumitani H; Okada S
    Anticancer Res; 1996; 16(1):533-5. PubMed ID: 8615666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a non cystatin-C-based novel algorithm to calculate individual glomerular filtration rate in cancer patients receiving carboplatin.
    Holweger K; Lipp HP; Beijnen JH; Bokemeyer C; Hartmann JT
    Cancer Chemother Pharmacol; 2011 Sep; 68(3):693-701. PubMed ID: 21136060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacokinetics and dose optimisation of carboplatin.
    Duffull SB; Robinson BA
    Clin Pharmacokinet; 1997 Sep; 33(3):161-83. PubMed ID: 9314610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of carboplatin AUC dosing in patients with a BMI>or=27 or cachexia.
    Herrington JD; Tran HT; Riggs MW
    Cancer Chemother Pharmacol; 2006 Jan; 57(2):241-7. PubMed ID: 16133538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboplatin dosing for adult Japanese patients.
    Ando Y; Shimokata T; Yasuda Y; Hasegawa Y
    Nagoya J Med Sci; 2014 Feb; 76(1-2):1-9. PubMed ID: 25129986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboplatin dosing in overweight and obese patients with normal renal function, does weight matter?
    Ekhart C; Rodenhuis S; Schellens JH; Beijnen JH; Huitema AD
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):115-22. PubMed ID: 18989671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of pharmacokinetically guided dosing of carboplatin in Japanese patients with cancer.
    Shimokata T; Ando Y; Yasuda Y; Hamada A; Kawada K; Saito H; Matsuo S; Kondo M; Imaizumi K; Hasegawa Y
    Cancer Sci; 2010 Dec; 101(12):2601-5. PubMed ID: 20860621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of residual renal function with an increase in dialysis: haemodialysis versus peritoneal dialysis.
    Teruel-Briones JL; Fernández-Lucas M; Rivera-Gorrin M; Ruiz-Roso G; Díaz-Domínguez M; Rodríguez-Mendiola N; Quereda-Rodríguez-Navarro C
    Nefrologia; 2013; 33(5):640-9. PubMed ID: 24089155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of carboplatin in a patient suffering from advanced ovarian carcinoma with hemodialysis-dependent renal insufficiency.
    Chatelut E; Rostaing L; Gualano V; Vissac T; De Forni M; Ton-That H; Suc JM; Houin G; Canal P
    Nephron; 1994; 66(2):157-61. PubMed ID: 8139735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboplatin dosing: gender bias and inaccurate estimates of glomerular filtration rate.
    Dooley MJ; Poole SG; Rischin D; Webster LK
    Eur J Cancer; 2002 Jan; 38(1):44-51. PubMed ID: 11750838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.